RGD1309170 Inhibitors
The protein "similar to human chromosome 4 open reading frame 17" is a protein that is predicted to be encoded by a gene located on the fourth chromosome of the human genome. Within the context of genomic nomenclature, "open reading frame" (ORF) implies a sequence of DNA that could potentially be translated into a protein due to the presence of a start codon, followed by a series of codons encoding amino acids, and ending with a stop codon. The designation "similar to" indicates that this particular ORF has sequences that resemble other known protein-coding genes or proteins, suggesting potential similarities in structure or function.The characterization of such proteins typically comes from bioinformatic analyses where DNA or RNA sequencing data are used to predict the existence of protein-coding regions within the genome. An ORF like "chromosome 4 open reading frame 17" might be identified through these computational methods, but it requires further empirical studies to confirm its expression and to explore its biological role.
The precise functions of proteins like the one encoded by "chromosome 4 open reading frame 17" remain largely unknown until validated by experimental evidence. This evidence may include the detection of the protein in cells or tissues, determination of its three-dimensional structure, identification of its molecular interactions, and elucidation of its role in physiological or pathological processes. Proteins can potentially be involved in a myriad of cellular functions, ranging from enzymatic activities, signaling pathways, cellular structure, to regulatory mechanisms.The study of such proteins can provide significant insights into the complex mechanisms of cellular biology. As research progresses, proteins initially classified as "similar to" can become better understood, leading to potential implications for understanding human biology and disease.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol, a natural compound found in certain plants, has been suggested to modulate gene expression through various mechanisms, potentially impacting the expression of C4orf17. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin, known for its potential to modulate gene expression, may influence the expression of C4orf17 by impacting various signaling pathways and transcription factors. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $37.00 $77.00 $184.00 $510.00 $1224.00 $5814.00 | 8 | |
Niclosamide has been investigated for its ability to inhibit gene expression, potentially impacting the expression of C4orf17 through interference with specific signaling pathways and transcriptional regulators. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $56.00 $75.00 | 2 | |
Ivermectin has been found to potentially inhibit gene expression by interacting with nuclear transport proteins and impacting transcriptional regulation, potentially affecting the expression of C4orf17. | ||||||
Berberine | 2086-83-1 | sc-507337 | 250 mg | $90.00 | 1 | |
Berberine has been suggested to modulate gene expression through its effects on chromatin structure and various transcriptional regulators, potentially influencing the expression of C4orf17. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin gallate has been investigated for its ability to influence gene expression through various mechanisms, potentially affecting the expression of C4orf17 through modulation of transcriptional regulators. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $26.00 $50.00 $99.00 $150.00 $1887.00 | 40 | |
Luteolin has been suggested to inhibit gene expression through its effects on specific signaling pathways and transcription factors involved in gene regulation, potentially impacting the expression of C4orf17. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $32.00 $210.00 $720.00 $1128.00 $2302.00 $3066.00 $5106.00 | 22 | |
Apigenin has been found to potentially inhibit gene expression by impacting specific transcription factors and modulating chromatin structure, potentially affecting the expression of C4orf17. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin has been studied for its potential to modulate gene expression by influencing various signaling pathways and transcriptional regulators, potentially impacting the expression of C4orf17. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein has been investigated for its ability to inhibit gene expression through its effects on specific signaling pathways and modulation of transcriptional regulators, potentially impacting the expression of C4orf17. | ||||||